APA (7th ed.) Citation

GP, L., A, B., O, K., & A, D. (2026). Nesfatin-1 mitigates calcium oxalate nephropathy in mice through GPR12 receptor modulation and PKCα/NADPH oxidase pathway inhibition. Life sciences, 402, 124544. https://doi.org/10.1016/j.lfs.2026.124544

Chicago Style (17th ed.) Citation

GP, Lahane, Bhat A, Kulkarni O, and Dhar A. "Nesfatin-1 Mitigates Calcium Oxalate Nephropathy in Mice Through GPR12 Receptor Modulation and PKCα/NADPH Oxidase Pathway Inhibition." Life Sciences 402 (2026): 124544. https://doi.org/10.1016/j.lfs.2026.124544.

MLA (9th ed.) Citation

GP, Lahane, et al. "Nesfatin-1 Mitigates Calcium Oxalate Nephropathy in Mice Through GPR12 Receptor Modulation and PKCα/NADPH Oxidase Pathway Inhibition." Life Sciences, vol. 402, 2026, p. 124544, https://doi.org/10.1016/j.lfs.2026.124544.